Mineralys Therapeutics, Inc. (MLYS)

NMS – Real vaqt narxi. Valyuta: USD

29.26

-0.47 (-1.58%)

Yopilishda: May 12, 2026, 4:00 PM EDT

29.50

+0.24 (0.82%)

Bozor oldidan: May 13, 2026, 7:00 AM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

Mineralys Therapeutics, Inc. (MLYS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Mineralys Therapeutics, Inc. (MLYS)

Mineralys Therapeutics, Inc. (MLYS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Mineralys: 'Hold' As Hypertension OSA Data Barely Delivers And AstraZeneca On The Move

Mineralys Therapeutics, Inc. (MLYS) Q1 2026 Earnings Call Transcript

Mineralys Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference

Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026

Videolar

No Data

Press-relizlar

Mineralys Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference

Mineralys Therapeutics Appoints Jeffrey A. Munsie as Chief Legal Officer

Search stocks

Mineralys Therapeutics, Inc. (MLYS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Mineralys Therapeutics, Inc. (MLYS)

Mineralys Therapeutics, Inc. (MLYS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Mineralys: 'Hold' As Hypertension OSA Data Barely Delivers And AstraZeneca On The Move

Mineralys Therapeutics, Inc. (MLYS) Q1 2026 Earnings Call Transcript

Mineralys Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference

Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026

Videolar

No Data

Press-relizlar

Mineralys Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference

Mineralys Therapeutics Appoints Jeffrey A. Munsie as Chief Legal Officer